Menstrual disturbance and galactorrhea in people taking conventional antipsychotic medications

Experimental and Clinical Psychopharmacology

Volumn 14, Issue 4, 2006, Pages 459-460

  Thangavelu, Karthik ^a   Geetanjali, S ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b Institute of Orthopaedics and Traumatology   (India)

Author keywords

Antipsychotic medications; Endocrine side effects; Galactorrhea; Menstrual disturbance; Pregnancy and lactation

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; TRIFLUOPERAZINE;

ADULT; ARTICLE; CHILDBIRTH; CLINICAL ARTICLE; DOPAMINERGIC ACTIVITY; ENDOCRINE DISEASE; FEMALE; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENSTRUATION DISORDER; PREGNANCY; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AMENORRHEA; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; GALACTORRHEA; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; PREGNANCY;

EID: 33751213559     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.14.4.459     Document Type: Article

References (9)

1. Ghadirian, A. M., Chouinard, G. & Annable, L. (1982). Sexual dysfunction and plasma prolactin levels in neuroleptic treated schizophrenia. Journal of Nervous and Mental Disease, 170, 463-467.
2. Gingell, K. H., Darley, J. S., Lengua, C. A., & Baddela, P. (1993). Menstrual changes with antipsychotic drugs. British Journal of Psychiatry, 162, 127.
3. Helewell, J. S. E. (1998). Antipsychotic tolerability: The attitudes and perceptions of medical professionals, patients and caregivers towards side-effects of antipsychotic therapy. European Neuropsychopharmacology, 8, S248.
4. Perkins, D. (2003). Prolactin- and endocrine-related disorders in schizophrenia. In J. Meyer & H. Nasrallah (Eds.), Medical illness and schizophrenia (pp. 215-233). Washington, DC: American Psychiatric Press.
5. Speroff, S. (2000). Clinical gynecologic endocrinology and infertility. Philadelphia: Lippincott, Williams, & Wilkins.
6. Weick, A., & Haddad, P. M. (2003). Antipsychotic-induced hyperprolactinemia in women. Pathophysiology, Severity and Consequences, 182, 199-204.
7. Wesselmann, U., & Windgassen, K. (1995). Galactorrhea: Subjective response by schizophrenic patients. Acta Psychiatrica Scandinavica, 91, 152-155.
8. Windgassen, K., Wesselmann, U., & Schulze-Monking, H. (1996). Galactorrhoea and hyperprolactinaemia in schizophrenic patients on neuroleptics: Frequency and etiology. Neuropsychobiology, 33, 142-146.
9. World Health Organization (WHO). (1992). The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva, Switzerland: Author.